Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Delivery Rate and Abuse Potential
NCT03580525Phase 1Completed
- Sponsor
- Yale University
- Start
- Feb 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nicotine in nicotine dependence (5 arms), sponsored by Yale University. Primary endpoints: Peak Changes on Items of the Drug Effects Questionnaire (DEQ) - Stimulatory Effects up to 10 minutes and Peak Changes on Items of the Drug Effects Questionnaire (DEQ) - Pleasurable Effects up to 10 minutes. Started Feb 2019; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03580525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580525.